drugset / Trial / NCT01923649

SOMATULINE Autogel 90 mg IN DUMPING SYNDROME

NCT01923649

RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to assess if Somatuline autogel 90 mg is effective in the treatment of dumping syndrome.

Timeline

Start
2008-04
Primary completion
2013-12-02
Completion
2013-12-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Lanreotide Other / unclassified 90 mg Subcutaneous

Indications